A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants | MicrobiomeTrials
A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2024-11-04Est. Completion: 2025-05-17
Enrollment target: 28 participants
Locations
Richmond Pharmacology Ltd, London, United Kingdom
Other microbiome trials you might be interested in